References
- Abdel-Haq H, Cometa MF, Palmery M, Leone MG, Silvestrini B, Saso L. (2000). Relaxant effect of Hydrastis canadensis and its major alkaloids on guinea-pig isolated trachea. Pharmacol Toxicol, 87, 218–222.
- Chan SS, Choi AO, Jones RL, Lin G. (2006). Mechanisms underlying the vasorelaxing effects of butylidenephthalide, an active constituent of Ligusticum chuanxiong in rat isolated aorta. Eur J Pharmacol, 537, 111–117.
- Ghayur MN, Gilani AH. (2007). α-Adrenergic receptor mediated hypertensive and vasoconstrictor effects of dietary radish leaves extract. J Health Sci, 53, 151–155.
- Gilani AH, Khan A, Subhan F, Khan M. (2005a). Antispasmodic and bronchodilator activities of St. John’s wort are putatively mediated through dual inhibition of calcium influx and phosphodiesterase. Fund Clin Pharmacol, 19, 695–705.
- Gilani AH, Shah AJ, Ghayur MN, Majeed K. (2005b). Pharmacological basis for the use of turmeric in gastrointestinal and respiratory disorders. Life Sci, 76, 3089–3105.
- Gilani AH, Khan A, Ghayur MN, Ali SF, Herzig JW. (2006). Antispasmodic effect of Rooibos tea (Aspalathus linearis) is mediated predominantly through K+ channel activation. Basic Clin Pharmacol Toxicol, 99, 365–373.
- Gilani AH, Bashir S, Khan A. (2007). Pharmacological basis for the use of Borago officinalis in gastrointestinal, respiratory and cardiovascular disorders. J Ethnopharmacol, 114, 393–399.
- Gilani AH, Khan A, Raoof M, Ghayur MN, Siddiqui BS, Vohra W, Begum S. (2008a). Gastrointestinal, selective airways and urinary bladder relaxant effects of Hyoscyamus niger are mediated through dual blockade of muscarinic receptors and Ca2+ channels. Fund Clin Pharmacol, 22, 87–99.
- Gilani AH, Khan A, Ali T, Ajmal S. (2008b). Mechanisms underlying the antispasmodic and bronchodilatory properties of Terminalia bellerica fruit. J Ethnopharmacol, 116, 528–538.
- Gilani AH, Mehmood MH, Janbaz KH, Khan A, Saeed SA. (2009). Gut modulatory and antiplatelet activities of Viscum cruciatum. Pharm Biol, 47, 955–961.
- Gilani SN, Khan A, Gilani AH. (2010). Pharmacological basis for the medicinal use of Zanthoxylum armatum in gut, airways and cardiovascular disorders. Phytother Res, 24, 553–558.
- Kaneda T, Takeuchi Y, Matsui H, Shimizu K, Urakawa N, Nakajyo S. (2005). Inhibitory mechanism of papaverine on carbachol-induced contraction in bovine trachea. J Pharmacol Sci, 98, 275–282.
- Khan A, Gilani AH. (2008a). Cardiovascular inhibitory effects of Hyoscyamus niger. Methods Find Exp Clin Pharmacol, 30, 295–300.
- Khan A, Gilani AH. (2008b). Pharmacodynamic evaluation of Terminalia bellerica for its antihypertensive effect. J Food Drug Anal, 16, 6–14.
- Khan A, Gilani AH. (2009a). Antidiarrheal, antisecretory and bronchodilatory activities of Hypericum perforatum. Pharm Biol, 47, 962–967.
- Khan A, Gilani AH. (2009b). Antispasmodic and bronchodilator activities of Artemisia vulgaris are mediated through dual blockade of muscarinic receptors and calcium influx. J Ethnopharmacol, 126, 480–486.
- Musha S, Watanabe M, Ishida Y, Kato S, Konishi M, Tomoda A.(2005). A phenoxazine compound, 2-amino-4,4α-dihydro-4α-7-dimethyl-3H-phenoxazine-3-one reverses the phenylephrine or high-K+ induced contractions of smooth muscles in rat aorta and guinea-pig tenia cecum. Biol Pharm Bull, 28, 1521–1523.
- National Research Council (1996). Guide for the Care and Use of Laboratory Animals. Washington DC: National Academy Press, 1–7.
- Saegusa Y, Sugiyama A, Takahara A, Nagasawa Y, Hashimoto K. (2003). Relationship between phosphodiesterase inhibition induced by several Kampo medicines and smooth muscle relaxation of gastrointestinal tract tissues of rats. J Pharmacol Sci, 93, 62–68.